Affiliation:
1. SASTRA Deemed University
2. CSIR- Central Institute of Mining and Fuel Research
Abstract
Abstract
In the era of antiretroviral therapy, the prevalence of Cryptococcal infection among HIV patients in developed countries has decreased considerably. However, C. neoformans ranks top among the critical priority pathogen that affects a wide range of immunocompromised individuals. The threat of C. neoformans is because of its incredibly multifaceted intracellular survival capabilities. Cell membrane sterols especially ergosterol and enzymes of its biosynthetic pathway are considered fascinating drug targets because of their structural stability. In this study, the ergosterol biosynthetic enzymes were modeled and docked with furanone derivatives. Among the tested ligands Compound 6 has shown a potential interaction with Lanosterol 14 α- demethylase. This best docked protein-ligand complex was taken further to molecular dynamics simulation. In addition, an in vitro study was conducted to quantify the ergosterol in Compound 6 treated cells. Altogether the computational and in vitro study demonstrates that Compound 6 has anticryptococcal activity by targeting the biosynthetic pathway of ergosterol.
Publisher
Research Square Platform LLC
Reference43 articles.
1. Invasive fungal disease in humans: are we aware of the real impact ?;Firacative C,2020
2. Declerck, Fungicides With Contrasting Mode of Action Differentially Affect Hyphal Healing Mechanism in Gigaspora sp. and Rhizophagus irregularis;Rodriguez-morelos VH,2021
3. M. Nucci, K.A. Marr, Emerging Fungal Diseases, 41 (2005) 521–526.
4. M. Von Lilienfeld-toal, J. Wagener, H. Einsele, O.A. Cornely, O. Kurzai, New Treatments to Meet New Challenges, (2019). https://doi.org/10.3238/arztebl.2019.0271.
5. Trends in the Epidemiology of Opportunistic Fungal Infections: Predisposing Factors and the Impact of Antimicrobial Use Practices;Article R,2001